Publication Name	World Journal of Diabetes
Manuscript ID	100346
Country	Australia

Received	2024-08-14 05:38
Peer-Review Started	2024-08-15 00:05
To Make the First Decision
Return for Revision	2024-09-05 15:40
Revised	2024-09-09 08:28
Second Decision	2024-09-14 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-14 08:06
Articles in Press	2024-09-14 08:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-19 08:14
Publish the Manuscript Online	2024-09-26 08:51

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Surgical or medical treatment of obesity-associated type 2 diabetes-an increasing clinical conundrum
Manuscript Source	Invited Manuscript
All Author List	Ryan J Jalleh, Karen L Jones, Md Shahidul Islam, Lu Cai and Michael Horowitz
Funding Agency and Grant Number
Corresponding Author	Michael Horowitz, DSc, FRACP, MBBS, PhD, Professor, Department of Medicine, University of Adelaide, Level 5, AHMS Corner North Tce and George St, Adelaide 5000, Australia. michael.horowitz@adelaide.edu.au
Key Words	Glucagon-like peptide-1; Glucagon-like peptide-1 receptor agonist; Obesity; Diabetes; Weight loss; Bariatric surgery; Metabolic surgery; Hypoglycemia
Core Tip	Glucagon-like peptide-1 receptor agonist-based therapy should be considered for the remission of type 2 diabetes and weight loss as an alternative to bariatric surgery.
Publish Date	2024-09-26 08:51
Citation	<p>Jalleh RJ, Jones KL, Islam MS, Cai L, Horowitz M. Surgical or medical treatment of obesity-associated type 2 diabetes-an increasing clinical conundrum. <i>World J Diabetes</i> 2024; 15(10): 2036-2040</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i10/2036.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i10.2036

Full Article (PDF)	WJD-15-2036-with-cover.pdf
Manuscript File	100346_Auto_Edited_093736.docx
Answering Reviewers	100346-answering-reviewers.pdf
Audio Core Tip	100346-audio.mp3
Conflict-of-Interest Disclosure Form	100346-conflict-of-interest-statement.pdf
Copyright License Agreement	100346-copyright-assignment.pdf
Peer-review Report	100346-peer-reviews.pdf
Scientific Misconduct Check	100346-scientific-misconduct-check.png
Scientific Editor Work List	100346-scientific-editor-work-list.pdf
CrossCheck Report	100346-crosscheck-report.pdf